Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease

Identifieur interne : 001585 ( PascalFrancis/Corpus ); précédent : 001584; suivant : 001586

Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease

Auteurs : Chiara Balducci ; Laura Pierguidi ; Emanuele Persichetti ; Lucilla Parnetti ; Michele Sbaragli ; Carmelo Tassi ; Aldo Orlacchio ; Paolo Calabresi ; Tommaso Beccari ; Aroldo Rossi

Source :

RBID : Pascal:07-0393271

Descripteurs français

English descriptors

Abstract

Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of β-glucocerebrosidase and the activities of other lysosomal enzymes, α-mannosidase, β-mannosidase, β-hexosaminidase, and β-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of α-mannosidase, β-mannosidase, β-glucocerebrosidase, and β-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of β-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 22
A06       @2 10
A08 01  1  ENG  @1 Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
A11 01  1    @1 BALDUCCI (Chiara)
A11 02  1    @1 PIERGUIDI (Laura)
A11 03  1    @1 PERSICHETTI (Emanuele)
A11 04  1    @1 PARNETTI (Lucilla)
A11 05  1    @1 SBARAGLI (Michele)
A11 06  1    @1 TASSI (Carmelo)
A11 07  1    @1 ORLACCHIO (Aldo)
A11 08  1    @1 CALABRESI (Paolo)
A11 09  1    @1 BECCARI (Tommaso)
A11 10  1    @1 ROSSI (Aroldo)
A14 01      @1 Dipartimento di Medicina Interna, Università degli Studi di Perugia @2 Perugia @3 ITA @Z 1 aut. @Z 3 aut. @Z 5 aut. @Z 9 aut.
A14 02      @1 Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia @2 Perugia @3 ITA @Z 2 aut. @Z 4 aut. @Z 8 aut. @Z 10 aut.
A14 03      @1 Fondazione Santa Lucia, IRCCS @2 Roma @3 ITA @Z 2 aut. @Z 8 aut.
A14 04      @1 Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia @2 Perugia @3 ITA @Z 6 aut. @Z 7 aut.
A20       @1 1481-1484
A21       @1 2007
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000161473330170
A44       @0 0000 @1 © 2007 INIST-CNRS. All rights reserved.
A45       @0 15 ref.
A47 01  1    @0 07-0393271
A60       @1 P @3 CC
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of β-glucocerebrosidase and the activities of other lysosomal enzymes, α-mannosidase, β-mannosidase, β-hexosaminidase, and β-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of α-mannosidase, β-mannosidase, β-glucocerebrosidase, and β-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of β-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases.
C02 01  X    @0 002B17
C02 02  X    @0 002B17G
C02 03  X    @0 002B17A03
C03 01  X  FRE  @0 Système nerveux pathologie @5 01
C03 01  X  ENG  @0 Nervous system diseases @5 01
C03 01  X  SPA  @0 Sistema nervioso patología @5 01
C03 02  X  FRE  @0 Parkinson maladie @5 02
C03 02  X  ENG  @0 Parkinson disease @5 02
C03 02  X  SPA  @0 Parkinson enfermedad @5 02
C03 03  X  FRE  @0 Hydrolases @2 FE @5 09
C03 03  X  ENG  @0 Hydrolases @2 FE @5 09
C03 03  X  SPA  @0 Hydrolases @2 FE @5 09
C03 04  X  FRE  @0 Liquide céphalorachidien @5 10
C03 04  X  ENG  @0 Cerebrospinal fluid @5 10
C03 04  X  SPA  @0 Líquido cefalorraquídeo @5 10
C03 05  X  FRE  @0 Homme @5 11
C03 05  X  ENG  @0 Human @5 11
C03 05  X  SPA  @0 Hombre @5 11
C03 06  X  FRE  @0 α-Mannosidase @2 FE @5 12 @6 «α»-Mannosidase
C03 06  X  ENG  @0 α-Mannosidase @2 FE @5 12 @6 «α»-Mannosidase
C03 06  X  SPA  @0 α-Mannosidase @2 FE @5 12 @6 «α»-Mannosidase
C03 07  X  FRE  @0 β-Mannosidase @2 FE @5 13 @6 «β»-Mannosidase
C03 07  X  ENG  @0 β-Mannosidase @2 FE @5 13 @6 «β»-Mannosidase
C03 07  X  SPA  @0 β-Mannosidase @2 FE @5 13 @6 «β»-Mannosidase
C03 08  X  FRE  @0 β-N-Acetylhexosaminidase @2 FE @5 14 @6 «β-N»-Acetylhexosaminidase
C03 08  X  ENG  @0 β-N-Acetylhexosaminidase @2 FE @5 14 @6 «β-N»-Acetylhexosaminidase
C03 08  X  SPA  @0 β-N-Acetylhexosaminidase @2 FE @5 14 @6 «β-N»-Acetylhexosaminidase
C07 01  X  FRE  @0 Enzyme @2 FE
C07 01  X  ENG  @0 Enzyme @2 FE
C07 01  X  SPA  @0 Enzima @2 FE
C07 02  X  FRE  @0 O-Glycosidases @2 FE @6 «O»-Glycosidases
C07 02  X  ENG  @0 O-Glycosidases @2 FE @6 «O»-Glycosidases
C07 02  X  SPA  @0 O-Glycosidases @2 FE @6 «O»-Glycosidases
C07 03  X  FRE  @0 Glycosidases @2 FE
C07 03  X  ENG  @0 Glycosidases @2 FE
C07 03  X  SPA  @0 Glycosidases @2 FE
C07 04  X  FRE  @0 Encéphale pathologie @5 37
C07 04  X  ENG  @0 Cerebral disorder @5 37
C07 04  X  SPA  @0 Encéfalo patología @5 37
C07 05  X  FRE  @0 Extrapyramidal syndrome @5 38
C07 05  X  ENG  @0 Extrapyramidal syndrome @5 38
C07 05  X  SPA  @0 Extrapiramidal síndrome @5 38
C07 06  X  FRE  @0 Maladie dégénérative @5 39
C07 06  X  ENG  @0 Degenerative disease @5 39
C07 06  X  SPA  @0 Enfermedad degenerativa @5 39
C07 07  X  FRE  @0 Système nerveux central pathologie @5 40
C07 07  X  ENG  @0 Central nervous system disease @5 40
C07 07  X  SPA  @0 Sistema nervosio central patología @5 40
N21       @1 253
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 07-0393271 INIST
ET : Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
AU : BALDUCCI (Chiara); PIERGUIDI (Laura); PERSICHETTI (Emanuele); PARNETTI (Lucilla); SBARAGLI (Michele); TASSI (Carmelo); ORLACCHIO (Aldo); CALABRESI (Paolo); BECCARI (Tommaso); ROSSI (Aroldo)
AF : Dipartimento di Medicina Interna, Università degli Studi di Perugia/Perugia/Italie (1 aut., 3 aut., 5 aut., 9 aut.); Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia/Perugia/Italie (2 aut., 4 aut., 8 aut., 10 aut.); Fondazione Santa Lucia, IRCCS/Roma/Italie (2 aut., 8 aut.); Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia/Perugia/Italie (6 aut., 7 aut.)
DT : Publication en série; Courte communication, note brève; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 10; Pp. 1481-1484; Bibl. 15 ref.
LA : Anglais
EA : Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of β-glucocerebrosidase and the activities of other lysosomal enzymes, α-mannosidase, β-mannosidase, β-hexosaminidase, and β-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of α-mannosidase, β-mannosidase, β-glucocerebrosidase, and β-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of β-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases.
CC : 002B17; 002B17G; 002B17A03
FD : Système nerveux pathologie; Parkinson maladie; Hydrolases; Liquide céphalorachidien; Homme; α-Mannosidase; β-Mannosidase; β-N-Acetylhexosaminidase
FG : Enzyme; O-Glycosidases; Glycosidases; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie
ED : Nervous system diseases; Parkinson disease; Hydrolases; Cerebrospinal fluid; Human; α-Mannosidase; β-Mannosidase; β-N-Acetylhexosaminidase
EG : Enzyme; O-Glycosidases; Glycosidases; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease
SD : Sistema nervioso patología; Parkinson enfermedad; Hydrolases; Líquido cefalorraquídeo; Hombre; α-Mannosidase; β-Mannosidase; β-N-Acetylhexosaminidase
LO : INIST-20953.354000161473330170
ID : 07-0393271

Links to Exploration step

Pascal:07-0393271

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease</title>
<author>
<name sortKey="Balducci, Chiara" sort="Balducci, Chiara" uniqKey="Balducci C" first="Chiara" last="Balducci">Chiara Balducci</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pierguidi, Laura" sort="Pierguidi, Laura" uniqKey="Pierguidi L" first="Laura" last="Pierguidi">Laura Pierguidi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Fondazione Santa Lucia, IRCCS</s1>
<s2>Roma</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Persichetti, Emanuele" sort="Persichetti, Emanuele" uniqKey="Persichetti E" first="Emanuele" last="Persichetti">Emanuele Persichetti</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Parnetti, Lucilla" sort="Parnetti, Lucilla" uniqKey="Parnetti L" first="Lucilla" last="Parnetti">Lucilla Parnetti</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Sbaragli, Michele" sort="Sbaragli, Michele" uniqKey="Sbaragli M" first="Michele" last="Sbaragli">Michele Sbaragli</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tassi, Carmelo" sort="Tassi, Carmelo" uniqKey="Tassi C" first="Carmelo" last="Tassi">Carmelo Tassi</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Orlacchio, Aldo" sort="Orlacchio, Aldo" uniqKey="Orlacchio A" first="Aldo" last="Orlacchio">Aldo Orlacchio</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Calabresi, Paolo" sort="Calabresi, Paolo" uniqKey="Calabresi P" first="Paolo" last="Calabresi">Paolo Calabresi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Fondazione Santa Lucia, IRCCS</s1>
<s2>Roma</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Beccari, Tommaso" sort="Beccari, Tommaso" uniqKey="Beccari T" first="Tommaso" last="Beccari">Tommaso Beccari</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rossi, Aroldo" sort="Rossi, Aroldo" uniqKey="Rossi A" first="Aroldo" last="Rossi">Aroldo Rossi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">07-0393271</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0393271 INIST</idno>
<idno type="RBID">Pascal:07-0393271</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001585</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease</title>
<author>
<name sortKey="Balducci, Chiara" sort="Balducci, Chiara" uniqKey="Balducci C" first="Chiara" last="Balducci">Chiara Balducci</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Pierguidi, Laura" sort="Pierguidi, Laura" uniqKey="Pierguidi L" first="Laura" last="Pierguidi">Laura Pierguidi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Fondazione Santa Lucia, IRCCS</s1>
<s2>Roma</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Persichetti, Emanuele" sort="Persichetti, Emanuele" uniqKey="Persichetti E" first="Emanuele" last="Persichetti">Emanuele Persichetti</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Parnetti, Lucilla" sort="Parnetti, Lucilla" uniqKey="Parnetti L" first="Lucilla" last="Parnetti">Lucilla Parnetti</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Sbaragli, Michele" sort="Sbaragli, Michele" uniqKey="Sbaragli M" first="Michele" last="Sbaragli">Michele Sbaragli</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Tassi, Carmelo" sort="Tassi, Carmelo" uniqKey="Tassi C" first="Carmelo" last="Tassi">Carmelo Tassi</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Orlacchio, Aldo" sort="Orlacchio, Aldo" uniqKey="Orlacchio A" first="Aldo" last="Orlacchio">Aldo Orlacchio</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Calabresi, Paolo" sort="Calabresi, Paolo" uniqKey="Calabresi P" first="Paolo" last="Calabresi">Paolo Calabresi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Fondazione Santa Lucia, IRCCS</s1>
<s2>Roma</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Beccari, Tommaso" sort="Beccari, Tommaso" uniqKey="Beccari T" first="Tommaso" last="Beccari">Tommaso Beccari</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Rossi, Aroldo" sort="Rossi, Aroldo" uniqKey="Rossi A" first="Aroldo" last="Rossi">Aroldo Rossi</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cerebrospinal fluid</term>
<term>Human</term>
<term>Hydrolases</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>α-Mannosidase</term>
<term>β-Mannosidase</term>
<term>β-N-Acetylhexosaminidase</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Système nerveux pathologie</term>
<term>Parkinson maladie</term>
<term>Hydrolases</term>
<term>Liquide céphalorachidien</term>
<term>Homme</term>
<term>α-Mannosidase</term>
<term>β-Mannosidase</term>
<term>β-N-Acetylhexosaminidase</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of β-glucocerebrosidase and the activities of other lysosomal enzymes, α-mannosidase, β-mannosidase, β-hexosaminidase, and β-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of α-mannosidase, β-mannosidase, β-glucocerebrosidase, and β-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of β-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>22</s2>
</fA05>
<fA06>
<s2>10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>BALDUCCI (Chiara)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>PIERGUIDI (Laura)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>PERSICHETTI (Emanuele)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>PARNETTI (Lucilla)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>SBARAGLI (Michele)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>TASSI (Carmelo)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>ORLACCHIO (Aldo)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>CALABRESI (Paolo)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>BECCARI (Tommaso)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>ROSSI (Aroldo)</s1>
</fA11>
<fA14 i1="01">
<s1>Dipartimento di Medicina Interna, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Fondazione Santa Lucia, IRCCS</s1>
<s2>Roma</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia</s1>
<s2>Perugia</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>1481-1484</s1>
</fA20>
<fA21>
<s1>2007</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000161473330170</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>15 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>07-0393271</s0>
</fA47>
<fA60>
<s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of β-glucocerebrosidase and the activities of other lysosomal enzymes, α-mannosidase, β-mannosidase, β-hexosaminidase, and β-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of α-mannosidase, β-mannosidase, β-glucocerebrosidase, and β-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of β-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B17A03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Hydrolases</s0>
<s2>FE</s2>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Hydrolases</s0>
<s2>FE</s2>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Hydrolases</s0>
<s2>FE</s2>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Liquide céphalorachidien</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Cerebrospinal fluid</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Líquido cefalorraquídeo</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Homme</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Human</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>α-Mannosidase</s0>
<s2>FE</s2>
<s5>12</s5>
<s6>«α»-Mannosidase</s6>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>α-Mannosidase</s0>
<s2>FE</s2>
<s5>12</s5>
<s6>«α»-Mannosidase</s6>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>α-Mannosidase</s0>
<s2>FE</s2>
<s5>12</s5>
<s6>«α»-Mannosidase</s6>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>β-Mannosidase</s0>
<s2>FE</s2>
<s5>13</s5>
<s6>«β»-Mannosidase</s6>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>β-Mannosidase</s0>
<s2>FE</s2>
<s5>13</s5>
<s6>«β»-Mannosidase</s6>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>β-Mannosidase</s0>
<s2>FE</s2>
<s5>13</s5>
<s6>«β»-Mannosidase</s6>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>β-N-Acetylhexosaminidase</s0>
<s2>FE</s2>
<s5>14</s5>
<s6>«β-N»-Acetylhexosaminidase</s6>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>β-N-Acetylhexosaminidase</s0>
<s2>FE</s2>
<s5>14</s5>
<s6>«β-N»-Acetylhexosaminidase</s6>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>β-N-Acetylhexosaminidase</s0>
<s2>FE</s2>
<s5>14</s5>
<s6>«β-N»-Acetylhexosaminidase</s6>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Enzima</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>O-Glycosidases</s0>
<s2>FE</s2>
<s6>«O»-Glycosidases</s6>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>O-Glycosidases</s0>
<s2>FE</s2>
<s6>«O»-Glycosidases</s6>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>O-Glycosidases</s0>
<s2>FE</s2>
<s6>«O»-Glycosidases</s6>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Glycosidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Glycosidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Glycosidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21>
<s1>253</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 07-0393271 INIST</NO>
<ET>Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease</ET>
<AU>BALDUCCI (Chiara); PIERGUIDI (Laura); PERSICHETTI (Emanuele); PARNETTI (Lucilla); SBARAGLI (Michele); TASSI (Carmelo); ORLACCHIO (Aldo); CALABRESI (Paolo); BECCARI (Tommaso); ROSSI (Aroldo)</AU>
<AF>Dipartimento di Medicina Interna, Università degli Studi di Perugia/Perugia/Italie (1 aut., 3 aut., 5 aut., 9 aut.); Clinica Neurologica, Ospedale Santa Maria della Misericordia, Università degli Studi di Perugia/Perugia/Italie (2 aut., 4 aut., 8 aut., 10 aut.); Fondazione Santa Lucia, IRCCS/Roma/Italie (2 aut., 8 aut.); Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Università degli Studi di Perugia/Perugia/Italie (6 aut., 7 aut.)</AF>
<DT>Publication en série; Courte communication, note brève; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2007; Vol. 22; No. 10; Pp. 1481-1484; Bibl. 15 ref.</SO>
<LA>Anglais</LA>
<EA>Recent studies have shown a genetic association between glucocerebrosidase deficiencies and Parkinson's disease (PD). To further explore this issue the activity of β-glucocerebrosidase and the activities of other lysosomal enzymes, α-mannosidase, β-mannosidase, β-hexosaminidase, and β-galactosidase have been evaluated in the cerebrospinal fluid (CSF) of PD patients. The activities of α-mannosidase, β-mannosidase, β-glucocerebrosidase, and β-hexosaminidase were substantially decreased in the CSF of PD patients, while levels of β-galactosidase were essentially identical to controls. This study indicates that in PD several lysosomal hydrolases have decreased activities, further supporting a possible link between pathophysiological mechanisms underlying PD and lysosomal hydrolases.</EA>
<CC>002B17; 002B17G; 002B17A03</CC>
<FD>Système nerveux pathologie; Parkinson maladie; Hydrolases; Liquide céphalorachidien; Homme; α-Mannosidase; β-Mannosidase; β-N-Acetylhexosaminidase</FD>
<FG>Enzyme; O-Glycosidases; Glycosidases; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Système nerveux central pathologie</FG>
<ED>Nervous system diseases; Parkinson disease; Hydrolases; Cerebrospinal fluid; Human; α-Mannosidase; β-Mannosidase; β-N-Acetylhexosaminidase</ED>
<EG>Enzyme; O-Glycosidases; Glycosidases; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Central nervous system disease</EG>
<SD>Sistema nervioso patología; Parkinson enfermedad; Hydrolases; Líquido cefalorraquídeo; Hombre; α-Mannosidase; β-Mannosidase; β-N-Acetylhexosaminidase</SD>
<LO>INIST-20953.354000161473330170</LO>
<ID>07-0393271</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001585 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001585 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:07-0393271
   |texte=   Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024